<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-28T10:38:35Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/94514" metadataPrefix="rdf">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/94514</identifier><datestamp>2025-03-18T14:11:51Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:docta.ucm.es:20.500.14352/94514">
      <dc:title>Surfactant Protein A Prevents IFN-γ/IFN-γ Receptor Interaction and Attenuates Classical Activation of Human Alveolar Macrophages</dc:title>
      <dc:creator>Minutti, Carlos</dc:creator>
      <dc:creator>García-Fojeda García-Valdecasas, María Belén</dc:creator>
      <dc:creator>Sáenz, Alejandra </dc:creator>
      <dc:creator>Casas-Engel, Mateo de las </dc:creator>
      <dc:creator>Guillamat-Prats, Raquel </dc:creator>
      <dc:creator>Lorenzo, Alba de </dc:creator>
      <dc:creator>Serrano-Mollar, Anna </dc:creator>
      <dc:creator>Corbí, Ängel</dc:creator>
      <dc:creator>Casals Carro, María Cristina</dc:creator>
      <dc:description>Lung surfactant protein A (SP-A) plays an important function in modulating inflammation in the lung. However, the exact role of SP-A and the mechanism by which SP-A affects IFN-γ–induced activation of alveolar macrophages (aMϕs) remains unknown. To address these questions, we studied the effect of human SP-A on rat and human aMϕs stimulated with IFN-γ, LPS, and combinations thereof and measured the induction of proinflammatory mediators as well as SP-A’s ability to bind to IFN-γ or IFN-γR1. We found that SP-A inhibited (IFN-γ + LPS)–induced TNF-α, iNOS, and CXCL10 production by rat aMϕs. When rat macrophages were stimulated with LPS and IFN-γ separately, SP-A inhibited both LPS-induced signaling and IFN-γ–elicited STAT1 phosphorylation. SP-A also decreased TNF-α and CXCL10 secretion by ex vivo–cultured human aMϕs and M-CSF–derived macrophages stimulated by either LPS or IFN-γ or both. Hence, SP-A inhibited upregulation of IFN-γ–inducible genes (CXCL10, RARRES3, and ETV7) as well as STAT1 phosphorylation in human M-CSF–derived macrophages. In addition, we found that SP-A bound to human IFN-γ (KD = 11 ± 0.5 nM) in a Ca2+-dependent manner and prevented IFN-γ interaction with IFN-γR1 on human aMϕs. We conclude that SP-A inhibition of (IFN-γ + LPS) stimulation is due to SP-A attenuation of both inflammatory agents and that the binding of SP-A to IFN-γ abrogates IFN-γ effects on human macrophages, suppressing their classical activation and subsequent inflammatory response.</dc:description>
      <dc:date>2024-01-22T17:24:10Z</dc:date>
      <dc:date>2024-01-22T17:24:10Z</dc:date>
      <dc:date>2016</dc:date>
      <dc:type>journal article</dc:type>
      <dc:identifier>Carlos M. Minutti, Belén García-Fojeda, Alejandra Sáenz, Mateo de las Casas-Engel, Raquel Guillamat-Prats, Alba de Lorenzo, Anna Serrano-Mollar, Ángel L. Corbí, Cristina Casals; Surfactant Protein A Prevents IFN-γ/IFN-γ Receptor Interaction and Attenuates Classical Activation of Human Alveolar Macrophages. J Immunol 15 July 2016; 197 (2): 590–598. https://doi.org/10.4049/jimmunol.1501032</dc:identifier>
      <dc:identifier>0022-1767</dc:identifier>
      <dc:identifier>10.4049/jimmunol.1501032</dc:identifier>
      <dc:identifier>https://hdl.handle.net/20.500.14352/94514</dc:identifier>
      <dc:identifier>1550-6606</dc:identifier>
      <dc:identifier>https://doi.org/10.4049/jimmunol.1501032</dc:identifier>
      <dc:identifier>https://pubmed.ncbi.nlm.nih.gov/27271568/</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:relation>info:eu-repo/grantAgreement/MINECO//SAF2012-32728/ES/EL SURFACTANTE PULMONAR COMO AGENTE PROTECTOR Y MODULADOR DE LA INFLAMACION E INFECCION EN EL PULMON/</dc:relation>
      <dc:relation>info:eu-repo/grantAgreement/MINECO//SAF2015-65307-R/ES/FACTORES ANTI-INFECCIOSOS DEL PULMON COMO NUEVAS ESTRATEGIAS TERAPEUTICAS FRENTE A INFECCIONES RESPIRATORIAS/</dc:relation>
      <dc:relation>info:eu-repo/grantAgreement/MINECO//SAF2014-52423-R/ES/MODULACION DE LA ACTIVACION DE MACROFAGOS Y DE PATOLOGIAS INFLAMATORIAS POR ACTIVINA A Y SEROTONINA/</dc:relation>
      <dc:relation>FIS-PI13/00282</dc:relation>
      <dc:relation>CIBERES-CB06/06/0002</dc:relation>
      <dc:relation>MTV3 122410</dc:relation>
      <dc:relation>AP2010-1524</dc:relation>
      <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
      <dc:rights>open access</dc:rights>
      <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
      <dc:publisher>The American Association of Immunologists</dc:publisher>
   </ow:Publication>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>